Previous close | 48.07 |
Open | 47.78 |
Bid | 41.00 x 900 |
Ask | 46.92 x 800 |
Day's range | 45.78 - 47.78 |
52-week range | 21.06 - 66.47 |
Volume | |
Avg. volume | 501,950 |
Market cap | 2.527B |
Beta (5Y monthly) | 0.41 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
DUBLIN, Ireland, March 21, 2023--Prothena announced today that members of its senior management team will participate in a fireside chat at Stifel 2023 Virtual CNS Days on March 28 .
DUBLIN, March 14, 2023--Prothena announced broad participation at AD/PD 2023 highlighting leadership in advancing treatments for Alzheimer’s and Parkinson’s disease
DUBLIN, February 23, 2023--Prothena Corporation plc today reported financial results for the 4th quarter and full year 2022.